Constellation’s Epigenetic Inhibitors Show Early Signs of Activity in Advanced Lymphoma Patients
News
Two investigative compounds targeting epigenetic DNA modification have shown encouraging preliminary activity in B-cell lymphoma patients, according to results from two Phase 1 trials. The inhibitors, called CPI-1205 and CPI-0610, were found to ... Read more